Marshall Wace’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,918
Closed -$269K 2863
2025
Q1
$269K Buy
+15,918
New +$271K ﹤0.01% 2304
2024
Q4
Sell
-33,777
Closed -$734K 2725
2024
Q3
$734K Buy
+33,777
New +$755K ﹤0.01% 1775
2024
Q1
Sell
-15,600
Closed -$451K 2578
2023
Q4
$451K Buy
15,600
+2,968
+23% +$79.4K ﹤0.01% 1751
2023
Q3
$338K Buy
12,632
+6,416
+103% +$219K ﹤0.01% 1844
2023
Q2
$230K Buy
+6,216
New +$217K ﹤0.01% 2213
2023
Q1
Sell
-6,900
Closed -$205K 2835
2022
Q4
$205K Sell
6,900
-49,109
-88% -$1.76M ﹤0.01% 2698
2022
Q3
$2.13M Buy
+56,009
New +$2.81M 0.01% 1964
2022
Q1
Sell
-10,876
Closed -$1.09M 3579
2021
Q4
$1.09M Sell
10,876
-43,610
-80% -$3.83M ﹤0.01% 2437
2021
Q3
$4.9M Buy
54,486
+47,663
+699% +$4.33M 0.02% 951
2021
Q2
$629K Sell
6,823
-49,955
-88% -$3.99M ﹤0.01% 2028
2021
Q1
$5.49M Buy
56,778
+15,756
+38% +$1.63M 0.03% 781
2020
Q4
$2.14M Buy
+41,022
New +$1.71M 0.01% 923

Other funds holding FLGT